Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease
- PMID: 36993878
- PMCID: PMC10033154
- DOI: 10.1016/j.molstruc.2023.135409
Synthesis, molecular docking, and binding Gibbs free energy calculation of β-nitrostyrene derivatives: Potential inhibitors of SARS-CoV-2 3CL protease
Abstract
The outbreak of novel coronavirus disease 2019 (COVID-19), caused by the novel coronavirus (SARS-CoV-2), has had a significant impact on human health and the economic development. SARS-CoV-2 3CL protease (3CLpro) is highly conserved and plays a key role in mediating the transcription of virus replication. It is an ideal target for the design and screening of anti-coronavirus drugs. In this work, seven β-nitrostyrene derivatives were synthesized by Henry reaction and β-dehydration reaction, and their inhibitory effects on SARS-CoV-2 3CL protease were identified by enzyme activity inhibition assay in vitro. Among them, 4-nitro-β-nitrostyrene (compound a) showed the lowest IC50 values of 0.7297 µM. To investigate the key groups that determine the activity of β-nitrostyrene derivatives and their interaction mode with the receptor, the molecular docking using the CDOCKER protocol in Discovery Studio 2016 was performed. The results showed that the hydrogen bonds between β-NO2 and receptor GLY-143 and the π-π stacking between the aryl ring of the ligand and the imidazole ring of receptor HIS-41 significantly contributed to the ligand activity. Furthermore, the ligand-receptor absolute binding Gibbs free energies were calculated using the Binding Affinity Tool (BAT.py) to verify its correlation with the activity of β-nitrostyrene 3CLpro inhibitors as a scoring function. The higher correlation(r2=0.6) indicates that the absolute binding Gibbs free energy based on molecular dynamics can be used to predict the activity of new β-nitrostyrene 3CLpro inhibitors. These results provide valuable insights for the functional group-based design, structure optimization and the discovery of high accuracy activity prediction means of anti-COVID-19 lead compounds.
Keywords: 3CLpro inhibitor; Binding Gibbs free energies; Molecular docking; Receptor-ligand interaction; SARS-CoV-2; β-nitrostyrene derivatives.
© 2023 Published by Elsevier B.V.
Conflict of interest statement
All co-authors declare that there are no conflicts of interest.
Figures
References
-
- Health World. Organization COVID-19 vaccine tracker. and landscape. 2022
-
- Hashimoto M., Nagata N., Homma T., Maeda H., Dohi K., Seki N.M., Yoshihara K., Iwata-Yoshikawa N., Shiwa-Sudo N., Sakai Y., Shirakura M., Kishida N., Arita T., Suzuki Y., Watanabe S., Asanuma H., Sonoyama T., Suzuki T., Omoto S., Hasegawa H. Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys. Vaccine. 2022;40(31):4231–4241. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
